Spots Global Cancer Trial Database for stage iic
Every month we try and update this database with for stage iic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma | NCT01456104 | Melanoma | Langerhans-type... | - | Memorial Sloan Kettering Cancer Center | |
Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma | NCT01456104 | Melanoma | Langerhans-type... | - | Memorial Sloan Kettering Cancer Center | |
A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery | NCT05608291 | Melanoma | Fianlimab Cemiplimab Pembrolizumab Placebo | 12 Years - | Regeneron Pharmaceuticals |